世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

ビルダグリプチン錠剤の世界市場成長 2023-2029


Global Vildagliptin Tablets Market Growth 2023-2029

Vildagliptin Tabletsの世界市場規模は2022年の100万米ドルから2029年には100万米ドルに成長すると予測されており、2023年から2029年までの年平均成長率は%であると予測されている。 Vildagliptin Tabletsの米国... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 言語
LP Information
LPインフォメーション 		2023年6月23日 US$3,660
シングルユーザライセンス
ライセンス・価格情報・注文方法はこちら 		115 英語

　

サマリー

Vildagliptin Tabletsの世界市場規模は2022年の100万米ドルから2029年には100万米ドルに成長すると予測されており、2023年から2029年までの年平均成長率は%であると予測されている。
Vildagliptin Tabletsの米国市場規模は2022年の100万米ドルから2029年には100万米ドルになると予測され、2023年から2029年までの年平均成長率は%である。
Vildagliptin Tabletsの中国市場は、2023年から2029年までの年平均成長率%で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定される。
Vildagliptin Tabletsのヨーロッパ市場は、2023年から2029年までの年平均成長率%で、2022年の百万米ドルから2029年には百万米ドルに増加すると推定される。
世界の主要なビルダグリプチン錠のプレーヤーは、Novartis Farmaceutica SA.、Siegfried Barbera S.L.、武田薬品、メルク、第一三共、長江薬業（集団）有限公司、Hybio Pharmaceutical Co.Ltd.、KP Pharmacy Co.Ltd.、Jiangsu Desano Pharmaceutical Co.Ltd.などをカバーしています。売上高では、世界の大手2社が2022年にほぼ％のシェアを占めている。
LPI（LPインフォメーション）の最新リサーチレポート「ビルダグリプチン錠の産業予測」は、過去の売上高を調査し、2022年の世界のビルダグリプチン錠の総売上高をレビューし、2023年から2029年までのビルダグリプチン錠の予測売上高を地域別・市場分野別に包括的に分析しています。本レポートでは、ビルダグリプチン錠の売上高を地域別、市場分野別、サブセクター別に分類し、世界のビルダグリプチン錠産業の詳細な分析を百万米ドル単位で提供しています。
本インサイトレポートでは、世界のVildagliptin Tabletsの状況を包括的に分析し、製品セグメンテーション、企業形成、売上高、市場シェア、最新動向、M&A活動に関する主要動向を明らかにしています。また本レポートでは、Vildagliptin Tabletsのポートフォリオと能力、市場参入戦略、市場での地位、地理的な足跡に焦点を当てて、主要グローバル企業の戦略を分析し、加速するVildagliptin Tabletsの世界市場におけるこれらの企業の独自の地位をより深く理解しています。
本インサイトレポートでは、Vildagliptin錠剤の世界的な見通しを形成する主要な市場動向、促進要因、影響要因を評価し、タイプ別、用途別、地域別、市場規模別に予測を細分化して、新たな機会のポケットを浮き彫りにします。何百ものボトムアップの質的・量的市場インプットに基づいた透明性の高い手法により、本調査予測は世界のVildagliptin錠剤の現状と将来の軌道について非常にニュアンスのある見解を提供します。
当レポートでは、Vildagliptin錠剤市場の製品タイプ別、用途別、主要メーカー別、主要地域別および国別の包括的な概要、市場シェア、成長機会を紹介しています。
市場のセグメンテーション
タイプ別セグメンテーション
通常のビルダグリプチン錠
メトホルミン塩酸塩・ビルダグリプチン錠
用途別セグメント
病院
クリニック
小売薬局
その他
本レポートは地域別にも市場を分割しています：
南北アメリカ
アメリカ
カナダ
メキシコ
ブラジル
APAC
中国
日本
韓国
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東・アフリカ
エジプト
南アフリカ
イスラエル
トルコ
GCC諸国
以下の企業は、一次専門家から収集したインプットと、企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。
ノバルティス・ファルマチェウティカSA
ジークフリード・バーベラS.L.
武田薬品
メルク
第一三共
長江薬業（集団）有限公司
ハイビオ・ファーマシューティカル
KPファーマシー
江蘇德佐能薬業有限公司
南京三合目医薬有限公司
麒麟製薬股份有限公司
南京洋行医薬有限公司
合肥英泰医薬有限公司
海南綜合三陽薬業有限公司
漢創薬業集団有限公司
煙台万倫薬業有限公司
中国資源賽科薬業股份有限公司
山東蘭諾製薬有限公司
山東玉新製薬有限公司
本レポートで扱う主な質問
世界のビルダグリプチン錠剤市場の10年見通しは？
世界および地域別のビルダグリプチン錠市場成長の要因は何か？
市場別・地域別に最も急成長する技術は何か？
ビルダグリプチン錠の市場機会は最終市場規模によってどのように異なるのか？
ビルダグリプチン錠のタイプ別、用途別の内訳は？
COVID-19とロシア・ウクライナ戦争の影響は？


ページTOPに戻る


目次

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vildagliptin Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vildagliptin Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vildagliptin Tablets by Country/Region, 2018, 2022 & 2029
2.2 Vildagliptin Tablets Segment by Type
2.2.1 Ordinary Vildagliptin Tablets
2.2.2 Metformin Hydrochloride and Vildagliptin Tablets
2.3 Vildagliptin Tablets Sales by Type
2.3.1 Global Vildagliptin Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Vildagliptin Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vildagliptin Tablets Sale Price by Type (2018-2023)
2.4 Vildagliptin Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Vildagliptin Tablets Sales by Application
2.5.1 Global Vildagliptin Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Vildagliptin Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vildagliptin Tablets Sale Price by Application (2018-2023)
3 Global Vildagliptin Tablets by Company
3.1 Global Vildagliptin Tablets Breakdown Data by Company
3.1.1 Global Vildagliptin Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Vildagliptin Tablets Sales Market Share by Company (2018-2023)
3.2 Global Vildagliptin Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Vildagliptin Tablets Revenue by Company (2018-2023)
3.2.2 Global Vildagliptin Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Vildagliptin Tablets Sale Price by Company
3.4 Key Manufacturers Vildagliptin Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vildagliptin Tablets Product Location Distribution
3.4.2 Players Vildagliptin Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vildagliptin Tablets by Geographic Region
4.1 World Historic Vildagliptin Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Vildagliptin Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vildagliptin Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vildagliptin Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Vildagliptin Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vildagliptin Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vildagliptin Tablets Sales Growth
4.4 APAC Vildagliptin Tablets Sales Growth
4.5 Europe Vildagliptin Tablets Sales Growth
4.6 Middle East & Africa Vildagliptin Tablets Sales Growth
5 Americas
5.1 Americas Vildagliptin Tablets Sales by Country
5.1.1 Americas Vildagliptin Tablets Sales by Country (2018-2023)
5.1.2 Americas Vildagliptin Tablets Revenue by Country (2018-2023)
5.2 Americas Vildagliptin Tablets Sales by Type
5.3 Americas Vildagliptin Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vildagliptin Tablets Sales by Region
6.1.1 APAC Vildagliptin Tablets Sales by Region (2018-2023)
6.1.2 APAC Vildagliptin Tablets Revenue by Region (2018-2023)
6.2 APAC Vildagliptin Tablets Sales by Type
6.3 APAC Vildagliptin Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vildagliptin Tablets by Country
7.1.1 Europe Vildagliptin Tablets Sales by Country (2018-2023)
7.1.2 Europe Vildagliptin Tablets Revenue by Country (2018-2023)
7.2 Europe Vildagliptin Tablets Sales by Type
7.3 Europe Vildagliptin Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vildagliptin Tablets by Country
8.1.1 Middle East & Africa Vildagliptin Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vildagliptin Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Vildagliptin Tablets Sales by Type
8.3 Middle East & Africa Vildagliptin Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vildagliptin Tablets
10.3 Manufacturing Process Analysis of Vildagliptin Tablets
10.4 Industry Chain Structure of Vildagliptin Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vildagliptin Tablets Distributors
11.3 Vildagliptin Tablets Customer
12 World Forecast Review for Vildagliptin Tablets by Geographic Region
12.1 Global Vildagliptin Tablets Market Size Forecast by Region
12.1.1 Global Vildagliptin Tablets Forecast by Region (2024-2029)
12.1.2 Global Vildagliptin Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vildagliptin Tablets Forecast by Type
12.7 Global Vildagliptin Tablets Forecast by Application
13 Key Players Analysis
13.1 Novartis Farmaceutica SA.
13.1.1 Novartis Farmaceutica SA. Company Information
13.1.2 Novartis Farmaceutica SA. Vildagliptin Tablets Product Portfolios and Specifications
13.1.3 Novartis Farmaceutica SA. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Farmaceutica SA. Main Business Overview
13.1.5 Novartis Farmaceutica SA. Latest Developments
13.2 Siegfried Barbera S.L.
13.2.1 Siegfried Barbera S.L. Company Information
13.2.2 Siegfried Barbera S.L. Vildagliptin Tablets Product Portfolios and Specifications
13.2.3 Siegfried Barbera S.L. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Siegfried Barbera S.L. Main Business Overview
13.2.5 Siegfried Barbera S.L. Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Vildagliptin Tablets Product Portfolios and Specifications
13.3.3 Takeda Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Vildagliptin Tablets Product Portfolios and Specifications
13.4.3 Merck Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Vildagliptin Tablets Product Portfolios and Specifications
13.5.3 Daiichi Sankyo Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.7 Hybio Pharmaceutical Co., Ltd.
13.7.1 Hybio Pharmaceutical Co., Ltd. Company Information
13.7.2 Hybio Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.7.3 Hybio Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hybio Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Hybio Pharmaceutical Co., Ltd. Latest Developments
13.8 KP Pharmacy Co., Ltd.
13.8.1 KP Pharmacy Co., Ltd. Company Information
13.8.2 KP Pharmacy Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.8.3 KP Pharmacy Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 KP Pharmacy Co., Ltd. Main Business Overview
13.8.5 KP Pharmacy Co., Ltd. Latest Developments
13.9 Jiangsu Desano Pharmaceutical Co., Ltd.
13.9.1 Jiangsu Desano Pharmaceutical Co., Ltd. Company Information
13.9.2 Jiangsu Desano Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.9.3 Jiangsu Desano Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Jiangsu Desano Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Jiangsu Desano Pharmaceutical Co., Ltd. Latest Developments
13.10 Nanjing Sanhome Pharmaceutical Co.Ltd.,
13.10.1 Nanjing Sanhome Pharmaceutical Co.Ltd., Company Information
13.10.2 Nanjing Sanhome Pharmaceutical Co.Ltd., Vildagliptin Tablets Product Portfolios and Specifications
13.10.3 Nanjing Sanhome Pharmaceutical Co.Ltd., Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nanjing Sanhome Pharmaceutical Co.Ltd., Main Business Overview
13.10.5 Nanjing Sanhome Pharmaceutical Co.Ltd., Latest Developments
13.11 QILU Pharmaceutical Co., Ltd.
13.11.1 QILU Pharmaceutical Co., Ltd. Company Information
13.11.2 QILU Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.11.3 QILU Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 QILU Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 QILU Pharmaceutical Co., Ltd. Latest Developments
13.12 Nanjing YOKO Pharmaceutical Co., Ltd.
13.12.1 Nanjing YOKO Pharmaceutical Co., Ltd. Company Information
13.12.2 Nanjing YOKO Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.12.3 Nanjing YOKO Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nanjing YOKO Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Nanjing YOKO Pharmaceutical Co., Ltd. Latest Developments
13.13 Hefei Yingtai Pharmaceutical Co., Ltd.
13.13.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.13.2 Hefei Yingtai Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.13.3 Hefei Yingtai Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.14 Hainan General Sanyang Pharmaceutical Co., Ltd.
13.14.1 Hainan General Sanyang Pharmaceutical Co., Ltd. Company Information
13.14.2 Hainan General Sanyang Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.14.3 Hainan General Sanyang Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hainan General Sanyang Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Hainan General Sanyang Pharmaceutical Co., Ltd. Latest Developments
13.15 Hansoh Pharmaceutical Group Company Limited
13.15.1 Hansoh Pharmaceutical Group Company Limited Company Information
13.15.2 Hansoh Pharmaceutical Group Company Limited Vildagliptin Tablets Product Portfolios and Specifications
13.15.3 Hansoh Pharmaceutical Group Company Limited Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Hansoh Pharmaceutical Group Company Limited Main Business Overview
13.15.5 Hansoh Pharmaceutical Group Company Limited Latest Developments
13.16 Yantai Wanrun Pharmaceutical Co., Ltd.
13.16.1 Yantai Wanrun Pharmaceutical Co., Ltd. Company Information
13.16.2 Yantai Wanrun Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.16.3 Yantai Wanrun Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Yantai Wanrun Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Yantai Wanrun Pharmaceutical Co., Ltd. Latest Developments
13.17 China Resources SAIKE Pharmaceutical Co., Ltd.
13.17.1 China Resources SAIKE Pharmaceutical Co., Ltd. Company Information
13.17.2 China Resources SAIKE Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.17.3 China Resources SAIKE Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 China Resources SAIKE Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 China Resources SAIKE Pharmaceutical Co., Ltd. Latest Developments
13.18 Shandong Langnuo Pharmaceutical Co., Ltd.
13.18.1 Shandong Langnuo Pharmaceutical Co., Ltd. Company Information
13.18.2 Shandong Langnuo Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.18.3 Shandong Langnuo Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Shandong Langnuo Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Shandong Langnuo Pharmaceutical Co., Ltd. Latest Developments
13.19 Shandong YUXIN Pharmaceutical Co., Ltd.
13.19.1 Shandong YUXIN Pharmaceutical Co., Ltd. Company Information
13.19.2 Shandong YUXIN Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.19.3 Shandong YUXIN Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shandong YUXIN Pharmaceutical Co., Ltd. Main Business Overview
13.19.5 Shandong YUXIN Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る


　

Summary

The global Vildagliptin Tablets market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Vildagliptin Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Vildagliptin Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Vildagliptin Tablets is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Vildagliptin Tablets players cover Novartis Farmaceutica SA., Siegfried Barbera S.L., Takeda, Merck, Daiichi Sankyo, Yangtze River Pharmaceutical (Group) Co., Ltd., Hybio Pharmaceutical Co., Ltd., KP Pharmacy Co., Ltd. and Jiangsu Desano Pharmaceutical Co., Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
LPI (LP Information)' newest research report, the “Vildagliptin Tablets Industry Forecast” looks at past sales and reviews total world Vildagliptin Tablets sales in 2022, providing a comprehensive analysis by region and market sector of projected Vildagliptin Tablets sales for 2023 through 2029. With Vildagliptin Tablets sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Vildagliptin Tablets industry.
This Insight Report provides a comprehensive analysis of the global Vildagliptin Tablets landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Vildagliptin Tablets portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Vildagliptin Tablets market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Vildagliptin Tablets and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Vildagliptin Tablets.
This report presents a comprehensive overview, market shares, and growth opportunities of Vildagliptin Tablets market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Ordinary Vildagliptin Tablets
Metformin Hydrochloride and Vildagliptin Tablets
Segmentation by application
Hospital
Clinic
Retail Pharmacy
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Novartis Farmaceutica SA.
Siegfried Barbera S.L.
Takeda
Merck
Daiichi Sankyo
Yangtze River Pharmaceutical (Group) Co., Ltd.
Hybio Pharmaceutical Co., Ltd.
KP Pharmacy Co., Ltd.
Jiangsu Desano Pharmaceutical Co., Ltd.
Nanjing Sanhome Pharmaceutical Co.Ltd.,
QILU Pharmaceutical Co., Ltd.
Nanjing YOKO Pharmaceutical Co., Ltd.
Hefei Yingtai Pharmaceutical Co., Ltd.
Hainan General Sanyang Pharmaceutical Co., Ltd.
Hansoh Pharmaceutical Group Company Limited
Yantai Wanrun Pharmaceutical Co., Ltd.
China Resources SAIKE Pharmaceutical Co., Ltd.
Shandong Langnuo Pharmaceutical Co., Ltd.
Shandong YUXIN Pharmaceutical Co., Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Vildagliptin Tablets market?
What factors are driving Vildagliptin Tablets market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Vildagliptin Tablets market opportunities vary by end market size?
How does Vildagliptin Tablets break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?



ページTOPに戻る


Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Vildagliptin Tablets Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Vildagliptin Tablets by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Vildagliptin Tablets by Country/Region, 2018, 2022 & 2029
2.2 Vildagliptin Tablets Segment by Type
2.2.1 Ordinary Vildagliptin Tablets
2.2.2 Metformin Hydrochloride and Vildagliptin Tablets
2.3 Vildagliptin Tablets Sales by Type
2.3.1 Global Vildagliptin Tablets Sales Market Share by Type (2018-2023)
2.3.2 Global Vildagliptin Tablets Revenue and Market Share by Type (2018-2023)
2.3.3 Global Vildagliptin Tablets Sale Price by Type (2018-2023)
2.4 Vildagliptin Tablets Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Retail Pharmacy
2.4.4 Others
2.5 Vildagliptin Tablets Sales by Application
2.5.1 Global Vildagliptin Tablets Sale Market Share by Application (2018-2023)
2.5.2 Global Vildagliptin Tablets Revenue and Market Share by Application (2018-2023)
2.5.3 Global Vildagliptin Tablets Sale Price by Application (2018-2023)
3 Global Vildagliptin Tablets by Company
3.1 Global Vildagliptin Tablets Breakdown Data by Company
3.1.1 Global Vildagliptin Tablets Annual Sales by Company (2018-2023)
3.1.2 Global Vildagliptin Tablets Sales Market Share by Company (2018-2023)
3.2 Global Vildagliptin Tablets Annual Revenue by Company (2018-2023)
3.2.1 Global Vildagliptin Tablets Revenue by Company (2018-2023)
3.2.2 Global Vildagliptin Tablets Revenue Market Share by Company (2018-2023)
3.3 Global Vildagliptin Tablets Sale Price by Company
3.4 Key Manufacturers Vildagliptin Tablets Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Vildagliptin Tablets Product Location Distribution
3.4.2 Players Vildagliptin Tablets Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Vildagliptin Tablets by Geographic Region
4.1 World Historic Vildagliptin Tablets Market Size by Geographic Region (2018-2023)
4.1.1 Global Vildagliptin Tablets Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Vildagliptin Tablets Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Vildagliptin Tablets Market Size by Country/Region (2018-2023)
4.2.1 Global Vildagliptin Tablets Annual Sales by Country/Region (2018-2023)
4.2.2 Global Vildagliptin Tablets Annual Revenue by Country/Region (2018-2023)
4.3 Americas Vildagliptin Tablets Sales Growth
4.4 APAC Vildagliptin Tablets Sales Growth
4.5 Europe Vildagliptin Tablets Sales Growth
4.6 Middle East & Africa Vildagliptin Tablets Sales Growth
5 Americas
5.1 Americas Vildagliptin Tablets Sales by Country
5.1.1 Americas Vildagliptin Tablets Sales by Country (2018-2023)
5.1.2 Americas Vildagliptin Tablets Revenue by Country (2018-2023)
5.2 Americas Vildagliptin Tablets Sales by Type
5.3 Americas Vildagliptin Tablets Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Vildagliptin Tablets Sales by Region
6.1.1 APAC Vildagliptin Tablets Sales by Region (2018-2023)
6.1.2 APAC Vildagliptin Tablets Revenue by Region (2018-2023)
6.2 APAC Vildagliptin Tablets Sales by Type
6.3 APAC Vildagliptin Tablets Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Vildagliptin Tablets by Country
7.1.1 Europe Vildagliptin Tablets Sales by Country (2018-2023)
7.1.2 Europe Vildagliptin Tablets Revenue by Country (2018-2023)
7.2 Europe Vildagliptin Tablets Sales by Type
7.3 Europe Vildagliptin Tablets Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Vildagliptin Tablets by Country
8.1.1 Middle East & Africa Vildagliptin Tablets Sales by Country (2018-2023)
8.1.2 Middle East & Africa Vildagliptin Tablets Revenue by Country (2018-2023)
8.2 Middle East & Africa Vildagliptin Tablets Sales by Type
8.3 Middle East & Africa Vildagliptin Tablets Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Vildagliptin Tablets
10.3 Manufacturing Process Analysis of Vildagliptin Tablets
10.4 Industry Chain Structure of Vildagliptin Tablets
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Vildagliptin Tablets Distributors
11.3 Vildagliptin Tablets Customer
12 World Forecast Review for Vildagliptin Tablets by Geographic Region
12.1 Global Vildagliptin Tablets Market Size Forecast by Region
12.1.1 Global Vildagliptin Tablets Forecast by Region (2024-2029)
12.1.2 Global Vildagliptin Tablets Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Vildagliptin Tablets Forecast by Type
12.7 Global Vildagliptin Tablets Forecast by Application
13 Key Players Analysis
13.1 Novartis Farmaceutica SA.
13.1.1 Novartis Farmaceutica SA. Company Information
13.1.2 Novartis Farmaceutica SA. Vildagliptin Tablets Product Portfolios and Specifications
13.1.3 Novartis Farmaceutica SA. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Novartis Farmaceutica SA. Main Business Overview
13.1.5 Novartis Farmaceutica SA. Latest Developments
13.2 Siegfried Barbera S.L.
13.2.1 Siegfried Barbera S.L. Company Information
13.2.2 Siegfried Barbera S.L. Vildagliptin Tablets Product Portfolios and Specifications
13.2.3 Siegfried Barbera S.L. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Siegfried Barbera S.L. Main Business Overview
13.2.5 Siegfried Barbera S.L. Latest Developments
13.3 Takeda
13.3.1 Takeda Company Information
13.3.2 Takeda Vildagliptin Tablets Product Portfolios and Specifications
13.3.3 Takeda Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Takeda Main Business Overview
13.3.5 Takeda Latest Developments
13.4 Merck
13.4.1 Merck Company Information
13.4.2 Merck Vildagliptin Tablets Product Portfolios and Specifications
13.4.3 Merck Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Merck Main Business Overview
13.4.5 Merck Latest Developments
13.5 Daiichi Sankyo
13.5.1 Daiichi Sankyo Company Information
13.5.2 Daiichi Sankyo Vildagliptin Tablets Product Portfolios and Specifications
13.5.3 Daiichi Sankyo Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Daiichi Sankyo Main Business Overview
13.5.5 Daiichi Sankyo Latest Developments
13.6 Yangtze River Pharmaceutical (Group) Co., Ltd.
13.6.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
13.6.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.6.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Main Business Overview
13.6.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Latest Developments
13.7 Hybio Pharmaceutical Co., Ltd.
13.7.1 Hybio Pharmaceutical Co., Ltd. Company Information
13.7.2 Hybio Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.7.3 Hybio Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Hybio Pharmaceutical Co., Ltd. Main Business Overview
13.7.5 Hybio Pharmaceutical Co., Ltd. Latest Developments
13.8 KP Pharmacy Co., Ltd.
13.8.1 KP Pharmacy Co., Ltd. Company Information
13.8.2 KP Pharmacy Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.8.3 KP Pharmacy Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 KP Pharmacy Co., Ltd. Main Business Overview
13.8.5 KP Pharmacy Co., Ltd. Latest Developments
13.9 Jiangsu Desano Pharmaceutical Co., Ltd.
13.9.1 Jiangsu Desano Pharmaceutical Co., Ltd. Company Information
13.9.2 Jiangsu Desano Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.9.3 Jiangsu Desano Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Jiangsu Desano Pharmaceutical Co., Ltd. Main Business Overview
13.9.5 Jiangsu Desano Pharmaceutical Co., Ltd. Latest Developments
13.10 Nanjing Sanhome Pharmaceutical Co.Ltd.,
13.10.1 Nanjing Sanhome Pharmaceutical Co.Ltd., Company Information
13.10.2 Nanjing Sanhome Pharmaceutical Co.Ltd., Vildagliptin Tablets Product Portfolios and Specifications
13.10.3 Nanjing Sanhome Pharmaceutical Co.Ltd., Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Nanjing Sanhome Pharmaceutical Co.Ltd., Main Business Overview
13.10.5 Nanjing Sanhome Pharmaceutical Co.Ltd., Latest Developments
13.11 QILU Pharmaceutical Co., Ltd.
13.11.1 QILU Pharmaceutical Co., Ltd. Company Information
13.11.2 QILU Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.11.3 QILU Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 QILU Pharmaceutical Co., Ltd. Main Business Overview
13.11.5 QILU Pharmaceutical Co., Ltd. Latest Developments
13.12 Nanjing YOKO Pharmaceutical Co., Ltd.
13.12.1 Nanjing YOKO Pharmaceutical Co., Ltd. Company Information
13.12.2 Nanjing YOKO Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.12.3 Nanjing YOKO Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Nanjing YOKO Pharmaceutical Co., Ltd. Main Business Overview
13.12.5 Nanjing YOKO Pharmaceutical Co., Ltd. Latest Developments
13.13 Hefei Yingtai Pharmaceutical Co., Ltd.
13.13.1 Hefei Yingtai Pharmaceutical Co., Ltd. Company Information
13.13.2 Hefei Yingtai Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.13.3 Hefei Yingtai Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.13.4 Hefei Yingtai Pharmaceutical Co., Ltd. Main Business Overview
13.13.5 Hefei Yingtai Pharmaceutical Co., Ltd. Latest Developments
13.14 Hainan General Sanyang Pharmaceutical Co., Ltd.
13.14.1 Hainan General Sanyang Pharmaceutical Co., Ltd. Company Information
13.14.2 Hainan General Sanyang Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.14.3 Hainan General Sanyang Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.14.4 Hainan General Sanyang Pharmaceutical Co., Ltd. Main Business Overview
13.14.5 Hainan General Sanyang Pharmaceutical Co., Ltd. Latest Developments
13.15 Hansoh Pharmaceutical Group Company Limited
13.15.1 Hansoh Pharmaceutical Group Company Limited Company Information
13.15.2 Hansoh Pharmaceutical Group Company Limited Vildagliptin Tablets Product Portfolios and Specifications
13.15.3 Hansoh Pharmaceutical Group Company Limited Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.15.4 Hansoh Pharmaceutical Group Company Limited Main Business Overview
13.15.5 Hansoh Pharmaceutical Group Company Limited Latest Developments
13.16 Yantai Wanrun Pharmaceutical Co., Ltd.
13.16.1 Yantai Wanrun Pharmaceutical Co., Ltd. Company Information
13.16.2 Yantai Wanrun Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.16.3 Yantai Wanrun Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.16.4 Yantai Wanrun Pharmaceutical Co., Ltd. Main Business Overview
13.16.5 Yantai Wanrun Pharmaceutical Co., Ltd. Latest Developments
13.17 China Resources SAIKE Pharmaceutical Co., Ltd.
13.17.1 China Resources SAIKE Pharmaceutical Co., Ltd. Company Information
13.17.2 China Resources SAIKE Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.17.3 China Resources SAIKE Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.17.4 China Resources SAIKE Pharmaceutical Co., Ltd. Main Business Overview
13.17.5 China Resources SAIKE Pharmaceutical Co., Ltd. Latest Developments
13.18 Shandong Langnuo Pharmaceutical Co., Ltd.
13.18.1 Shandong Langnuo Pharmaceutical Co., Ltd. Company Information
13.18.2 Shandong Langnuo Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.18.3 Shandong Langnuo Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.18.4 Shandong Langnuo Pharmaceutical Co., Ltd. Main Business Overview
13.18.5 Shandong Langnuo Pharmaceutical Co., Ltd. Latest Developments
13.19 Shandong YUXIN Pharmaceutical Co., Ltd.
13.19.1 Shandong YUXIN Pharmaceutical Co., Ltd. Company Information
13.19.2 Shandong YUXIN Pharmaceutical Co., Ltd. Vildagliptin Tablets Product Portfolios and Specifications
13.19.3 Shandong YUXIN Pharmaceutical Co., Ltd. Vildagliptin Tablets Sales, Revenue, Price and Gross Margin (2018-2023)
13.19.4 Shandong YUXIN Pharmaceutical Co., Ltd. Main Business Overview
13.19.5 Shandong YUXIN Pharmaceutical Co., Ltd. Latest Developments
14 Research Findings and Conclusion

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（その他（治療を主目的としない薬物））の最新刊レポート

LP Information 社の最新刊レポート

本レポートと同じKEY WORD（tablets）の最新刊レポート


よくあるご質問


LP Information社はどのような調査会社ですか?


LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/09/27　10:27

146.53 円

164.06 円

199.13 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.